Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 176 participants.
Also called NCT01011699
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 176 participants
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Registry
-
NCT01011699
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Terminated
Technical summary
Registry record NCT01011699. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2013-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
- Acronym
- NICOREN
- Condition
- Chronic Renal Failure
- Condition
- Hemodialysis
- Intervention (Drug)
- nicotinamide
- Intervention (Drug)
- sevelamer
- Intervention (Drug)
- cinacalcet
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
Record details
- Record id
cardio:ct-nct01011699- Content hash
97b42bf7c1dbc93a4a0ea67594000f099ea4b4370f35456a286d9f9c8308b72d